{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:03:27Z","timestamp":1772136207753,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Research Project of Jiangsu Health and Health Commission","award":["H2023069"],"award-info":[{"award-number":["H2023069"]}]},{"name":"Medical Research Project of Yancheng Health and Health Commission","award":["YK2023027"],"award-info":[{"award-number":["YK2023027"]}]},{"name":"Jiangsu Province Engineering Research Center for Cardiovascular and Cerebrovascular Disease and Cancer Prevention and Control"},{"name":"Jiangsu Higher Education Institution Innovative Research Team For Science and Technology"},{"name":"China International Medical Exchange Foundation Medical road Hengrui Diabetes metabolism Research Fund","award":["Z-2017-26-2202-4"],"award-info":[{"award-number":["Z-2017-26-2202-4"]}]},{"name":"Huaian City natural science research project","award":["HAB202302"],"award-info":[{"award-number":["HAB202302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68207-y","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T21:03:02Z","timestamp":1722027782000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of C5aR1-mediated hepatic macrophage efferocytosis in NASH"],"prefix":"10.1038","volume":"14","author":[{"given":"Xuan","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinna","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianping","family":"song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liucai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"issue":"1","key":"68207_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15(1), 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"68207_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review. Hepatology. 77(4), 1335\u20131347 (2023).","journal-title":"Hepatology."},{"issue":"1","key":"68207_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 64(1), 73\u201384 (2016).","journal-title":"Hepatology."},{"issue":"1","key":"68207_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","volume":"7","author":"X Xu","year":"2022","unstructured":"Xu, X. et al. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH). Signal Transduct. Target Ther. 7(1), 287 (2022).","journal-title":"Signal Transduct. Target Ther."},{"issue":"21","key":"68207_CR5","doi-asserted-by":"publisher","first-page":"9702","DOI":"10.7150\/thno.44297","volume":"10","author":"J Hu","year":"2020","unstructured":"Hu, J. et al. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder. Theranostics. 10(21), 9702\u20139720 (2020).","journal-title":"Theranostics."},{"issue":"42","key":"68207_CR6","doi-asserted-by":"publisher","first-page":"5286","DOI":"10.3748\/wjg.v16.i42.5286","volume":"16","author":"EM Brunt","year":"2010","unstructured":"Brunt, E. M. & Tiniakos, D. G. Histopathology of nonalcoholic fatty liver disease. World J. Gastroenterol. 16(42), 5286\u20135296 (2010).","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"68207_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","volume":"65","author":"E Buzzetti","year":"2016","unstructured":"Buzzetti, E., Pinzani, M. & Tsochatzis, E. A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 65(8), 1038\u20131048 (2016).","journal-title":"Metabolism."},{"issue":"4","key":"68207_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","volume":"147","author":"T Luedde","year":"2014","unstructured":"Luedde, T., Kaplowitz, N. & Schwabe, R. F. Cell death and cell death responses in liver disease: Mechanisms and clinical relevance. Gastroenterology. 147(4), 765-783.e4 (2014).","journal-title":"Gastroenterology."},{"issue":"7","key":"68207_CR9","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24(7), 908\u2013922 (2018).","journal-title":"Nat. Med."},{"issue":"6","key":"68207_CR10","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","volume":"76","author":"V Ratziu","year":"2022","unstructured":"Ratziu, V., Francque, S. & Sanyal, A. Breakthroughs in therapies for NASH and remaining challenges. J. Hepatol. 76(6), 1263\u20131278 (2022).","journal-title":"J. Hepatol."},{"issue":"2","key":"68207_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jhep.2022.02.031","volume":"77","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis. J. Hepatol. 77(2), 312\u2013325 (2022).","journal-title":"J. Hepatol."},{"issue":"5","key":"68207_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jhep.2021.12.012","volume":"76","author":"O Govaere","year":"2022","unstructured":"Govaere, O. et al. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. J. Hepatol. 76(5), 1001\u20131012 (2022).","journal-title":"J. Hepatol."},{"issue":"2","key":"68207_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108626","volume":"34","author":"S Daemen","year":"2021","unstructured":"Daemen, S. et al. Dynamic shifts in the composition of resident and recruited macrophages influence tissue remodeling in NASH. Cell Rep. 34(2), 108626 (2021).","journal-title":"Cell Rep."},{"issue":"2","key":"68207_CR14","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/apa.14106","volume":"107","author":"W Hu","year":"2018","unstructured":"Hu, W. et al. Serum complement factor 5a levels are associated with nonalcoholic fatty liver disease in obese children. Acta Paediatr. 107(2), 322\u2013327 (2018).","journal-title":"Acta Paediatr."},{"key":"68207_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652242","volume":"12","author":"F Silva de Fran\u00e7a","year":"2021","unstructured":"Silva de Fran\u00e7a, F. et al. C5a\u2013C5aR1 axis activation drives envenomation immunopathology by the Snake Naja annulifera. Front. Immunol. 12, 652242 (2021).","journal-title":"Front. Immunol."},{"issue":"19","key":"68207_CR16","doi-asserted-by":"publisher","first-page":"8619","DOI":"10.7150\/thno.45058","volume":"10","author":"P Ding","year":"2020","unstructured":"Ding, P. et al. C5aR1 is a master regulator in colorectal tumorigenesis via immune modulation. Theranostics. 10(19), 8619\u20138632 (2020).","journal-title":"Theranostics."},{"issue":"4","key":"68207_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.ccell.2018.09.003","volume":"34","author":"TR Medler","year":"2018","unstructured":"Medler, T. R. et al. Complement C5a fosters squamous carcinogenesis and limits T cell response to chemotherapy. Cancer Cell. 34(4), 561-578.e6 (2018).","journal-title":"Cancer Cell."},{"issue":"7836","key":"68207_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","volume":"588","author":"J Carvelli","year":"2020","unstructured":"Carvelli, J. et al. Association of COVID-19 inflammation with activation of the C5a\u2013C5aR1 axis. Nature. 588(7836), 146\u2013150 (2020).","journal-title":"Nature."},{"issue":"1","key":"68207_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/v11010039","volume":"11","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y. et al. Complement receptor C5aR1 inhibition reduces pyroptosis in hDPP4-transgenic mice infected with MERS-CoV. Viruses. 11(1), 39 (2019).","journal-title":"Viruses."},{"issue":"66","key":"68207_CR20","doi-asserted-by":"publisher","first-page":"eabf2489","DOI":"10.1126\/sciimmunol.abf2489","volume":"6","author":"N Niyonzima","year":"2021","unstructured":"Niyonzima, N. et al. Mitochondrial C5aR1 activity in macrophages controls IL-1\u03b2 production underlying sterile inflammation. Sci. Immunol. 6(66), eabf2489 (2021).","journal-title":"Sci. Immunol."},{"key":"68207_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.molimm.2016.05.006","volume":"75","author":"RL McCullough","year":"2016","unstructured":"McCullough, R. L. et al. Differential contribution of complement receptor C5aR in myeloid and non-myeloid cells in chronic ethanol-induced liver injury in mice. Mol. Immunol. 75, 122\u2013132 (2016).","journal-title":"Mol. Immunol."},{"issue":"11","key":"68207_CR22","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.3390\/ijms22115920","volume":"22","author":"H Hwangbo","year":"2021","unstructured":"Hwangbo, H. et al. Anti-inflammatory effect of auranofin on palmitic acid and LPS-induced inflammatory response by modulating TLR4 and NOX4-mediated NF-\u03baB signaling pathway in RAW2647 macrophages. Int. J. Mol. Sci. 22(11), 5920 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"68207_CR23","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2021.04.074","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal, F. et al. Preparing for the NASH epidemic: A call to action. Gastroenterology. 161(3), 1030-1042.e8 (2021).","journal-title":"Gastroenterology."},{"issue":"10290","key":"68207_CR24","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W. & Rinella, M. Non-alcoholic fatty liver disease. Lancet. 397(10290), 2212\u20132224 (2021).","journal-title":"Lancet."},{"issue":"9","key":"68207_CR25","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.immuni.2022.08.002","volume":"55","author":"M Guilliams","year":"2022","unstructured":"Guilliams, M. & Scott, C. L. Liver macrophages in health and disease. Immunity. 55(9), 1515\u20131529 (2022).","journal-title":"Immunity."},{"issue":"8","key":"68207_CR26","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1038\/s41423-021-00690-z","volume":"18","author":"T Wang","year":"2021","unstructured":"Wang, T. & Ma, C. The hepatic macrophage pool in NASH. Cell Mol. Immunol. 18(8), 2059\u20132060 (2021).","journal-title":"Cell Mol. Immunol."},{"issue":"6292","key":"68207_CR27","doi-asserted-by":"publisher","first-page":"aad1210","DOI":"10.1126\/science.aad1210","volume":"352","author":"G Arbore","year":"2016","unstructured":"Arbore, G. et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells. Science. 352(6292), aad1210 (2016).","journal-title":"Science."},{"key":"68207_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100889","volume":"76","author":"L Wang","year":"2020","unstructured":"Wang, L. & Hauenstein, A. V. The NLRP3 inflammasome: Mechanism of action, role in disease and therapies. Mol. Aspects Med. 76, 100889 (2020).","journal-title":"Mol. Aspects Med."},{"issue":"8","key":"68207_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","volume":"43","author":"RC Coll","year":"2022","unstructured":"Coll, R. C., Schroder, K. & Pelegr\u00edn, P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol. Sci. 43(8), 653\u2013668 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"68207_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cytogfr.2021.10.002","volume":"62","author":"Y Mao","year":"2021","unstructured":"Mao, Y. Apoptotic cell-derived metabolites in efferocytosis-mediated resolution of inflammation. Cytokine Growth Factor Rev. 62, 42\u201353 (2021).","journal-title":"Cytokine Growth Factor Rev."},{"key":"68207_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.839248","volume":"10","author":"Y Ge","year":"2022","unstructured":"Ge, Y., Huang, M. & Yao, Y. M. Efferocytosis and its role in inflammatory disorders. Front. Cell Dev. Biol. 10, 839248 (2022).","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"68207_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran, A. C., Yurdagul, A. Jr. & Tabas, I. Efferocytosis in health and disease. Nat. Rev. Immunol. 20(4), 254\u2013267 (2020).","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"68207_CR33","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.cmet.2021.10.015","volume":"33","author":"BD Gerlach","year":"2021","unstructured":"Gerlach, B. D. et al. Efferocytosis induces macrophage proliferation to help resolve tissue injury. Cell Metab. 33(12), 2445-2463.e8 (2021).","journal-title":"Cell Metab."},{"issue":"1","key":"68207_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.immuni.2022.11.013","volume":"56","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development. Immunity. 56(1), 58-77.e11 (2023).","journal-title":"Immunity."},{"issue":"10","key":"68207_CR35","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.14309\/ajg.0000000000000388","volume":"114","author":"S Gawrieh","year":"2019","unstructured":"Gawrieh, S. et al. Histologic findings of advanced fibrosis and cirrhosis in patients with nonalcoholic fatty liver disease who have normal aminotransferase levels. Am. J. Gastroenterol. 114(10), 1626\u20131635 (2019).","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"68207_CR36","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.cmet.2021.09.008","volume":"33","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing. Cell Metab. 33(10), 2004-2020.e9 (2021).","journal-title":"Cell Metab."}],"updated-by":[{"DOI":"10.1038\/s41598-025-07847-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68207-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68207-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68207-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T08:29:05Z","timestamp":1751272145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68207-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68207"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68207-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4166103\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-07847-0","URL":"https:\/\/doi.org\/10.1038\/s41598-025-07847-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17232"}}